BACKGROUND: The incidence of melanoma in the United States is increasing. Data on this disease in African-Americans is sparse. METHODS: Chart review of patients diagnozed with melanoma from 1975 to 1997 at Charity Hospital New Orleans (CHNO). Age, gender, anatomic distribution, histology, presenting stage, survival, and race were evaluated. RESULTS: Forty-four of 198 patients were African-American, of whom the majority developed cutaneous melanoma on the acral surface of the foot. African-American males were four times more likely to present with a cutaneous lesion than were African-American females. The median survival time for African-American with cutaneous lesions was 45 months, compared to 135 months for caucasians who were 3.6 times more likely to present with early disease (P < 0.05). TNM stage at presentation, and ulceration were significant, independent factors associated with a worse outcome in African-Americans. CONCLUSION: Overall survival time for African-Americans with cutaneous melanoma is significantly shorter than for caucasians with this disease. This trend may be attributable to the fact that African-Americans present with advanced disease. An increased level of awareness among both patients and health-care providers is necessary to identify African-Americans with melanoma at earlier stages of disease and to improve survival. Copyright 2001 Wiley-Liss, Inc.
BACKGROUND: The incidence of melanoma in the United States is increasing. Data on this disease in African-Americans is sparse. METHODS: Chart review of patients diagnozed with melanoma from 1975 to 1997 at Charity Hospital New Orleans (CHNO). Age, gender, anatomic distribution, histology, presenting stage, survival, and race were evaluated. RESULTS: Forty-four of 198 patients were African-American, of whom the majority developed cutaneous melanoma on the acral surface of the foot. African-American males were four times more likely to present with a cutaneous lesion than were African-American females. The median survival time for African-American with cutaneous lesions was 45 months, compared to 135 months for caucasians who were 3.6 times more likely to present with early disease (P < 0.05). TNM stage at presentation, and ulceration were significant, independent factors associated with a worse outcome in African-Americans. CONCLUSION: Overall survival time for African-Americans with cutaneous melanoma is significantly shorter than for caucasians with this disease. This trend may be attributable to the fact that African-Americans present with advanced disease. An increased level of awareness among both patients and health-care providers is necessary to identify African-Americans with melanoma at earlier stages of disease and to improve survival. Copyright 2001 Wiley-Liss, Inc.
Authors: Alan C Geller; Barbra A Dickerman; Jennifer M Taber; Laura A Dwyer; Anne M Hartman; Frank M Perna Journal: Prev Med Date: 2018-02-06 Impact factor: 4.018
Authors: Lindsay G Wich; Michelle W Ma; Leah S Price; Stanislav Sidash; Russell S Berman; Anna C Pavlick; George Miller; Umut Sarpel; Judith D Goldberg; Iman Osman Journal: J Community Health Date: 2011-06
Authors: Karen Kadela Collins; Ryan C Fields; Dadrie Baptiste; Ying Liu; Jeffrey Moley; Donna B Jeffe Journal: Ann Surg Oncol Date: 2011-04-09 Impact factor: 5.344
Authors: Ivan R Bristow; David Ar de Berker; Katharine M Acland; Richard J Turner; Jonathan Bowling Journal: J Foot Ankle Res Date: 2010-11-01 Impact factor: 2.303
Authors: Fidelis Mbunda; Mabula D McHembe; Phillipo L Chalya; Peter Rambau; Stephen E Mshana; Benson R Kidenya; Japhet M Gilyoma Journal: BMC Dermatol Date: 2012-09-28